Grants for For profit organizations other than small businesses - Science and Technology

This funding opportunity provides financial support for innovative projects that develop clean hydrogen production technologies using alternative feedstocks like biomass and waste, targeting a diverse range of applicants including businesses, educational institutions, and non-profits.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine to treat neurological diseases, aiming to advance health and wellness for residents through innovative, collaborative projects.

The Downtown Development Authority (DDA) of Lawrenceville, Georgia, has launched the Façade Grant Program to revitalize its downtown area. This program aligns with the DDA's mission to serve as a resource to the City Council for downtown revitalization through strategic land use planning, land banking, business recruitment and retention, and the execution of the community's vision for a vibrant and inclusive urban center. The grant specifically targets businesses within the Downtown Entertainment District, aiming to encourage and support exterior renovations that enhance the aesthetic appeal and overall vitality of the area. The primary beneficiaries of this program are businesses located within the Downtown Entertainment District. The impact goals are centered on improving the physical appearance of downtown buildings, stimulating economic activity, and fostering a more attractive and inclusive urban environment. By offering reimbursement for façade renovations, the DDA seeks to reduce the financial burden on businesses, thereby encouraging investment in property improvements and contributing to a more appealing downtown. The program prioritizes projects that enhance or update the exterior of buildings, including activities such as painting, restoration, stabilization, awning additions, and improved signage. Eligibility criteria dictate that projects must be within the Downtown Entertainment District, and reimbursement is solely for expenses incurred during exterior façade renovations. Furthermore, all projects must comply with applicable building, development, and zoning regulations, and properties on the National Historic Register require a preservation review. Expected outcomes include a visibly improved and more attractive downtown area, increased business investment in property aesthetics, and a boost in overall community pride and engagement. Measurable results for the program include the number of businesses participating, the total amount of grant funds disbursed, the types of renovations undertaken, and the completion of approved work within the stipulated twelve-month timeframe. The reimbursement structure, covering half of the total project cost up to $2,500 per grant, provides a tangible incentive for businesses to participate.

This grant provides funding to nonprofit organizations and public institutions in Montana for innovative community projects that promote humanities themes through storytelling, discussions, and public engagement.

This funding opportunity supports projects that develop and operate geologic field laboratories for carbon storage technology, targeting organizations with access to suitable sites for testing and advancing carbon capture solutions.

This program provides funding to support proactive engagement with local businesses in Pennsylvania, helping them to retain and expand by fostering strong relationships with economic and workforce development partners.

The FY24 OCRP Clinical Trial Translational Endpoints Research Award intends to support correlation of clinical trial-related data (e.g., biosample analysis, imaging, or epidemiological data) with clinical outcomes or responses to therapies. Correlative studies may be associated with a past, ongoing, or future clinical trial in order to associate various factors (genetic, DOD FY24 Ovarian Cancer Clinical Trial Translational Endpoints Research Award 4biochemical, environmental and others) with initiation, progression, metastasis, recurrence, prognosis, diagnosis or effect of intervention on ovarian cancer outcomes. The translational research should address high-impact or unmet needs in ovarian cancer. The proposed research may be hypothesis testing or may be designed to generate new hypotheses to be tested in follow-up clinical research. The award may not be used to directly support a clinical trial.

The Nebraska SBIR/STTR Initiative provides financial assistance to small businesses in Nebraska participating in the federal SBIR/STTR programs. This state initiative offers Phase 0 assistance to help businesses apply for federal Phase 1 funding and matching funds for successful Phase 1 and Phase 2 federal awards. The initiative aims to promote innovation and technology transfer among small businesses in Nebraska, with a total fund availability of up to $6 million per year. Grant renewed every year. Grant Annual opening/closing deadline: July 1st to June 30th

This program provides financial assistance to businesses in Wabasha for improving the exterior of their commercial or industrial buildings, promoting revitalization and private investment in the community.

The DoD Kidney Cancer, Clinical Trial Award is a funding opportunity aimed at supporting the implementation of clinical trials that have the potential to significantly impact the treatment or management of kidney cancer, with a focus on new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies.

This initiative provides $52.5 million in cash awards to teams developing innovative technologies for capturing carbon dioxide from the atmosphere, with a focus on promoting environmental equity and community benefits.

The Olive Smith Browning Charitable Trust provides grants to eligible 501(c)(3) organizations dedicated to charitable, religious, scientific, literary, or educational pursuits. The Trust's mission is aligned with fostering community well-being and development through support for a diverse range of program areas, including arts, culture, and humanities; education; environment and animal welfare; health; human services; public/society benefit; and religion. This broad scope reflects a commitment to addressing various societal needs and enriching the lives of individuals and communities. The primary beneficiaries of the Olive Smith Browning Charitable Trust's grants are organizations operating within Twin Falls, Idaho, reflecting a strong commitment to local impact. The Trust prioritizes supporting initiatives that demonstrably contribute to the betterment of this specific geographic area. While specific expected outcomes and measurable results are not explicitly detailed for individual grants, the overall goal is to empower organizations that provide essential services and foster positive change within their respective program areas. The Trust's grantmaking priorities are clearly focused on supporting organizations within Twin Falls, Idaho, indicating a strategic preference for concentrated local impact. This geographic focus allows the Trust to cultivate deeper relationships with grantees and potentially observe more direct and tangible results of its funding. The average grant size ranges from $2,500 to $10,000, with an average total giving per year of $35,000, suggesting a model that supports multiple smaller-to-medium sized projects annually. To be eligible for funding, organizations must hold exempt status under Section 501(c)(3) of the Internal Revenue Code. Applications are required to be submitted through an online grant application form, or an accessible alternative for assistive technology users. The Trust's strategic priorities are centered on consistent support for established non-profits within its focus areas in Twin Falls, contributing to the sustained health and vitality of the local community. While a formal "theory of change" is not explicitly stated, the practice of supporting a diverse array of foundational program areas within a specific geographic region suggests an implicit theory that targeted, consistent funding in these areas will lead to overall community improvement and resilience.

This ISO seeks solution summary and proposal submissions for projects that fall within the scope of the ARPA-H mission Resilient Systems Office (RSO). RSOs interest areas will address systemic challenges across the healthcare and public health landscape by investing in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care.Aspects of todays health and public health systems remain fragile due to systemic challenges, which include rising healthcare costs, inadequate healthcare coverage for significant populations, outdated infrastructure, and health disparities among different demographic groups. Acute challenges, such as hospital closures, supply chain disruptions, staffing shortages, cyber-attacks, public health crises, and the emergence of new diseases, further exacerbate existing fragilities, making it more difficult to maintain high standards of care. These challenges are compounded by the fact that systems remain fragmented, hindering the ability to gain comprehensive insights, make informed decisions, develop tailored interventions, and share critical health information between stakeholders.RSO seeks solution summaries and proposals that drive innovations to enhance the adaptability, reliability, and interoperability of the health ecosystem. Of interest are innovations that foster flexibility and enable adaptation to system stressors, so that people and systems remain well-positioned to deliver high-quality care and improve health outcomes. The following interest areas categorize the ground-breaking research we seek to support:Sociotechnical System Innovation: Innovate user-centric digital health tools, platforms, technologies, and intervention models that improve outcomes across the health continuum, including prevention, diagnosis, and treatment of physical, mental, and behavioral health. Approaches to build trust in the healthcare system and distribute high-quality health guidance in an understandable manner that improves patient outcomes. Novel real-time measurement tools to track health outcomes, evaluate post-market performance of new interventions, and enable convergence on the most effective strategies to improve the quality of care, especially for underserved communities. Other population centered innovations to create more resilient communities and subpopulations. Innovations might include aggregate improvements to quality of care and better physical, mental, and behavioral health outcomes for the health ecosystem.Health Ecosystem Integration: Novel ways to collect, protect, secure, integrate, analyze, communicate, and present health data, including but not limited to advances in privacy, cyber security, artificial intelligence with enhanced patient safety properties, low-code or no-code technologies, semantic approaches, and rapid integration techniques. Strategies and technologies to leverage homes, community centers, pharmacies, and other accessible locations to enable new modalities of high-quality care, expand the reach of clinical research, or integrate end-user feedback to rapidly iterate prototype designs. Approaches to strengthen the connectivity and interoperability of health data and devices to 5 enable the safe, secure, and seamless exchange of information among healthcare providers, researchers, and stakeholders. Other novel approaches to increase the interoperability of health-related systems in support of improved health outcomes and enhanced transparency across the health ecosystem.Adaptive Antifragile Solutions: Creative approaches to enhance the stability and dependability of the health ecosystem through new adaptive paradigms, methods that anticipate and mitigate disruptions before they occur, and enhancements to emergency response. Approaches that enable health infrastructure to rapidly integrate information from new sensors; create decision support tools; adapt supply chains, manufacturing, and logistics; and better leverage the workforce during public health emergencies. Novel methods to engineer resilient tissues, microbiomes, and biophysical systems to combat disease or maintain health. Other novel approaches to enhance adaptability and reduce fragility within the health ecosystem.Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, systems, or methodology. Specifically excluded are proposals that represent an evolutionary or incremental advance in the state of the art or technology that has reached the clinical trial stage. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission

The MMRDA mechanism is intended to fund the logical continuation of previously DOD-funded research or development efforts relevant to the above FY24 JWMRP Focus Areas with the highest potential to augment and accelerate medical product development and health care solutions for active-duty Service Members, their Families, Veterans, and/or the American public. Collaboration with DOD organizations is encouraged when this alliance would contribute to the success of the research effort, and any funds designated for DOD laboratories or activities should be identified in the application/proposal through submission of a Suggested Intragovernmental/Intramural Budget Form, Attachment 15. Applications/proposals from small businesses and/or partnerships with industry are also encouraged. The MMRDA mechanism supports a wide range of research projects, spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, and translational research. A Clinical Research or Clinical Trial Option is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices, and technologies. Note: Applications/proposals submitted under this option will be required to submit additional relevant application/proposal materials.

This funding opportunity provides financial support for innovative breast cancer research projects aimed at preventing the disease, understanding its recurrence, or improving treatment, targeting both early-stage and more developed studies from a range of eligible organizations and researchers.

**AMENDED on DECEMBER 11 2023**: The latest revision is posted as Amendment 18. Potential applicants are strongly encouraged to review the Amendment in its entirety, as it updates several sections. Specifically, ATTACHMENT 1: SPECIFIC TOPICS now includes Basic Research Topics N1-N4, with white papers due by 11:59pm EST on 5 February 2024. White papers may not be considered if they are received after this deadline. In addition, submissions to the general thrust areas in accordance with the requirements detailed in the BAA are also welcome. ** Please note that all correspondence must be sent to the appropriate Agency contact identified in Section 7. Agency Contacts. **

This grant provides funding for collaborative clinical trials aimed at improving the diagnosis and treatment of health issues related to military toxic exposures, targeting researchers and institutions involved in this critical area of study.

**CYCLE 4 POSTED ON 10 APRIL 2024. SEE ATTACHED UPDATED ANNOUNCEMENT FOR SPECIFIC TOPICS OF INTEREST IN CYCLE 4 AND SUBMISSION INFORMATION** **CYCLE 3, ORIGINALLY POSTED ON 21 MARCH 2023, IS UPDATED TO INCLUDE A QUESTION AND ANSWER DOCUMENT AND TO UPDATE THE SUBMISSION DATE TO 5 MAY 2023 BY 1700 EASTERN TIME** **CYCLE 3 POSTED ON 21 MARCH 2023. SEE ATTACHED UPDATED ANNOUNCEMENT FOR SPECIFIC TOPICS OF INTEREST IN CYCLE 3 AND SUBMISSION INFORMATION** **CYCLE 2 POSTED ON 8 FEBRUARY 2021. SEE ATTACHED UPDATED ANNOUNCEMENT FOR SPECIFIC TOPICS OF INTEREST IN CYCLE 2 AND SUBMISSION INFORMATION** Purpose: Future Army forces will need to conduct cross-domain maneuver (CDM) and at times, operate semi-independently, disbursed, and while communications and infrastructure such as Global Positioning System (GPS) are disrupted or denied. Robotics and Autonomous Systems (RAS) will play a key role in expanding the operational reach, situational awareness, and effectiveness of maneuver forces in CDM. The Combat Capabilities Development Command (CCDC) Army Research Laboratory (ARL) is focused on developing fundamental understanding and informing the art-of-the-possible for warfighter concepts through research to greatly improve air and ground based autonomous vehicle perception, learning, reasoning, communication, navigation, and physical capabilities to augment and increase the freedom of maneuver in complex and contested environments. The Scalable, Adaptive, and Resilient Autonomy (SARA) program is focused on developing and experimentally accelerating emerging research in autonomous mobility and maneuverability, scalable heterogeneous and collaborative behaviors, and human agent teaming to realize adaptive and resilient Intelligent Systems that can reason about the environment, work in distributed and collaborative heterogeneous teams, and make op-tempo decisions to enable Autonomous Maneuver in complex and contested environments. In order to achieve this vision, advancements are needed in following: Novel methods for all-terrain ground and aerial maneuver to interact with and move through complex environments. Methods for scalable and heterogeneous collaborative behaviors in support of collaborative air and ground manned-unmanned teaming operations. Techniques for improved perception, decision-making, and adaptive behaviors for fully autonomous maneuver in contested environments. Methods, metrics, and tools to facilitate, simulate, and enable testing and evaluation of emerging approaches for intelligent and autonomous systems under Army relevant constraints and environments Experimental testbeds to develop and refine knowledge products to inform and transition technology to Army stakeholders.

Error generating summary

This funding opportunity provides financial support to various organizations and institutions to help prevent adversaries from exploiting advanced technologies and commercial facilities for military purposes, focusing on enhancing global partnerships and security measures.